{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:26Z","timestamp":1791176846181,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1472-6874-8-23","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T19:14:06Z","timestamp":1232046846000},"source":"Crossref","is-referenced-by-count":23,"title":["New paradigms in cervical cancer prevention: opportunities and risks"],"prefix":"10.1186","volume":"8","author":[{"given":"Guglielmo","family":"Ronco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Giorgi Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,17]]},"reference":[{"key":"140_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJL, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T: Overview of the European and north American studies on HPV testing in primary cervical screening. Int J Cancer. 2006, 119: 1095-101. 10.1002\/ijc.21955.","journal-title":"Int J Cancer"},{"key":"140_CR2","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","volume":"26S","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJL: Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008, 26S: K29-K41. 10.1016\/j.vaccine.2008.06.019.","journal-title":"Vaccine"},{"key":"140_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","volume":"98","author":"G Ronco","year":"2006","unstructured":"Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, the NTCC Working Group: Human Papillomavirus testing and liquid-based cytology in primary cervical screening: results at recruitment from the NTCC randomized controlled trial. J Natl Cancer Inst. 2006, 98: 765-74.","journal-title":"J Natl Cancer Inst"},{"key":"140_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","volume":"7","author":"G Ronco","year":"2006","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco A, De Lillo M, Naldoni C, Pienotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J, the NTCC Working Group: Human papillomavirus testing and liquid-based cytology in primary screening among younger women: results at recruitment from the NTCC randomised controlled trial. Lancet Oncol. 2006, 7: 547-55. 10.1016\/S1470-2045(06)70731-8.","journal-title":"Lancet Oncol"},{"key":"140_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutl\u00e9e F, Franco EL, for the Canadian Cervical Cancer Screening Trial Study Group: Human papillomavirus DNA versus Papanicolau screening tests for cervical cancer. New Engl J Med. 2007, 357: 1579-88. 10.1056\/NEJMoa071430.","journal-title":"New Engl J Med"},{"key":"140_CR6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007, 370: 1764-72. 10.1016\/S0140-6736(07)61450-0.","journal-title":"Lancet"},{"key":"140_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler P, Ryd W, T\u00f6rnberg S, Strand A, Wadell G, Elfgren K, R\u00e5dberg T, Strander B, Forslund O, Hansson BG, Rylander E, Dillner J: Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007, 357: 1589-97. 10.1056\/NEJMoa073204.","journal-title":"N Engl J Med"},{"key":"140_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, the NTCC Working Group: Results at Recruitment from a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone to Conventional Cytology as the Primary Cervical Cancer Screening Test. J Natl Cancer Inst. 2008, 100: 492-501. 10.1093\/jnci\/djn065.","journal-title":"J Natl Cancer Inst"},{"key":"140_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","volume":"362","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P: Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003, 362: 1871-1876. 10.1016\/S0140-6736(03)14955-0.","journal-title":"Lancet"},{"key":"140_CR10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(07)61480-9","volume":"370","author":"G Ronco","year":"2007","unstructured":"Ronco G, Segnan N: Human papillomavirus testing for primary cervical cancer screening (invited comment). Lancet. 2007, 370: 1740-1742. 10.1016\/S0140-6736(07)61480-9.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"140_CR11","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.vaccine.2006.05.122","volume":"24","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Mayrand MH, Ronco G, Snijders P, Wardle J: Chapter 10: New dimensions in cervical cancer screening. Vaccine. 2006, 24 (Suppl 3): S90-7. 10.1016\/j.vaccine.2006.05.122.","journal-title":"Vaccine"},{"key":"140_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","volume":"9","author":"F Carozzi","year":"2008","unstructured":"Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Ponentani G, Rosso S, Sani C, Sintoni C, Segnan N, Cuzick J, Rizzolo R, Ronco G, the New Technologies for Cervical Cancer screening (NTCC) working group: Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol. 2008, 9: 937-45. 10.1016\/S1470-2045(08)70208-0.","journal-title":"Lancet Oncol"},{"key":"140_CR13","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/ijc.23055","volume":"121","author":"P Giorgi Rossi","year":"2007","unstructured":"Giorgi Rossi P, Segnan N, Zappa M, Naldoni C, Zorzi M, Confortini M, Merito M, Ronco G, the NTCC Working Group: The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective. Int J Cancer. 2007, 121: 2729-2734. 10.1002\/ijc.23055.","journal-title":"Int J Cancer"},{"key":"140_CR14","doi-asserted-by":"publisher","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C, Raifu Ao, Koilopulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E: Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta analysis. BMJ. 2008, 337: a1284-10.1136\/bmj.a1284.","journal-title":"BMJ"},{"key":"140_CR15","doi-asserted-by":"publisher","first-page":"a1343","DOI":"10.1136\/bmj.a1343","volume":"337","author":"S Albrechtsen","year":"2008","unstructured":"Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE: Pregnancy outcome in women before and after conisation: population based cohort study. BMJ. 2008, 337: a1343-10.1136\/bmj.a1343.","journal-title":"BMJ"},{"key":"140_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"Future II Study Group","year":"2007","unstructured":"Future II Study Group: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Eng J Med. 2007, 356: 1915-27. 10.1056\/NEJMoa061741.","journal-title":"N Eng J Med"},{"issue":"9580","key":"140_CR17","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"J Paavonen","year":"2007","unstructured":"Paavonen J, Jenkins D, Bosch FX, Naud P, Salmer\u00f3n J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G, HPV PATRICIA study group: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind randomised controlled trial. Lancet. 2007, 369 (9580): 2161-2170. 10.1016\/S0140-6736(07)60946-5.","journal-title":"Lancet"},{"issue":"33","key":"140_CR18","first-page":"pii: 18954","volume":"13","author":"LA King","year":"2008","unstructured":"King LA, Levy-Bruhl D, O'Flanagan D, Bacci S, Lopalco PL, Kudjawu Y, Salmaso S, VENICE country-specific gate keepers and contact points: Introduction of human papillomavirus into national immunisation schedules in Europe: results of the VENICE 2007 survey. Euro Surveill. 2008, 13 (33): pii: 18954.","journal-title":"Euro Surveill"},{"key":"140_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bjc.6604146","volume":"98","author":"FX Bosch","year":"2008","unstructured":"Bosch FX, Castellsagu\u00e9 X, de Sanjos\u00e9 S: HPV and cervical cancer: screening or vaccination?. Br J Cancer. 2008, 98: 15-21. 10.1038\/sj.bjc.6604146.","journal-title":"Br J Cancer"},{"key":"140_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jnci\/djn038","volume":"100","author":"NB Kiviat","year":"2008","unstructured":"Kiviat NB, Hawes SE, Feng Q: Screening for cervical cancer in the era of the HPV vaccine -the urgent need for both new screening guidelines and new biomarkers. J Natl Cancer Inst. 2008, 100: 290-1. 10.1093\/jnci\/djn038.","journal-title":"J Natl Cancer Inst"},{"key":"140_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet. 2007, 370: 890-907. 10.1016\/S0140-6736(07)61416-0.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"140_CR22","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.vaccine.2006.05.026","volume":"24","author":"G Clifford","year":"2006","unstructured":"Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL: Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006, 24 (Suppl 3): S26-34. 10.1016\/j.vaccine.2006.05.026.","journal-title":"Vaccine"},{"key":"140_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1309\/EWYGWFRRM8798U5P","volume":"129","author":"P Dalla Palma","year":"2008","unstructured":"Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Lestani M, Onnis GL, Aldovini D, Galanti G, Casadei GP, Aldi M, Gomes V, Giubilato P, Ronco G, the NTCC Pathology Group: The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histological lesions found in the NTCC trial. Am J Clin Pathol. 2008, 129: 75-80. 10.1309\/EWYGWFRRM8798U5P.","journal-title":"Am J Clin Pathol"},{"key":"140_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005, 97: 1072-9.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-8-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-8-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:37:19Z","timestamp":1548218239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-8-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-8-23","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"article-number":"23"}}